EFIC-Grünenthal Grant
Application 2014


Information on guidelines, timelines, the online application form as well as on former awards can be found at
 

www.e-g-g.info

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.

Grünenthal Group

The Grünenthal Group

The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany.

Building on its unique position in pain treatment, its objective is to become the most patient-centric company and thus to be a leader in therapy innovation. Grünenthal is one of the last remaining five research-oriented pharmaceutical companies with headquarters in Germany which sustainably invests in research and development. These investments amounted to about 26 percent of revenues in 2012.

Read more...

EFIC-GRÜNENTHAL Grant

Encouraging innovative pain research projects

Since 2004 Grünenthal GmbH in cooperation with the European Pain Federation EFIC® supports young scientists at an early stage of their experimental projects on clinical or human volunteer-based pain research. The EFIC-GRÜNENTHAL Grant is totaling 200,000 EUR, research grants are valued at up to EUR 40,000 per project.The application deadline for this year’s EFIC-GRÜNENTHAL Grant is set on 31 December 2014.

Read more...